Increased interleukin 33 in patients with neuro-Behcet's disease: Correlation with MCP-1 and IP-10 chemokines

Cellular and Molecular Immunology

Volumn 11, Issue 6, 2014, Pages 613-616

  Hamzaoui, Kamel ^a   Borhani Haghighi, Afshin ^b   Kaabachi, Wajih ^a   Hamzaoui, Agnes ^a,b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 33; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; BEHCET DISEASE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; HUMAN; NEURO BEHCET DISEASE; PROTEIN EXPRESSION; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; COMPLICATION; GENETICS; IMMUNOLOGY; METABOLISM; UPREGULATION;

BEHCET SYNDROME; CENTRAL NERVOUS SYSTEM DISEASES; CHEMOKINE CCL2; CHEMOKINE CXCL10; HUMANS; INTERLEUKINS; NF-KAPPA B; UP-REGULATION;

EID: 84907542047     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.31     Document Type: Article

References (10)

1. Farahangiz S, Sarhadi S, Safari A, Borhani-Haghighi A. Magnetic resonanceimaging findings and outcome of neuro-Behçet's disease: the predictive factors. Int J Rheum Dis 2012; 15: e142-e149
2. Saruhan-Direskeneli G, Yentür SP, Akman-Demir G, Işik N, Serdaroʇlu P. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003; 145: 127-134
3. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL- 33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-110
4. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-1080
5. Borhani Haghighi A. Treatment of neuro-Behçet's disease: an update. Expert Rev Neurother 2009; 9: 565-574
6. Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj- Sassi F. Serum IL-33 levels and skin mRNA expression in Behçet's disease. Clin Exp Rheumatol 2013; 31(3 Suppl 77): 6-14
7. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490
8. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT. Induction of IL-33 expression and activity in central nervous system glia. J LeukocBiol 2008; 84: 631-643
9. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288: L3-L15
10. Ali S, Mohs A, Thomas M, Klare J, Ross R, Schmitz ML et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kB to dampen NF-kB-stimulated gene transcription. J Immunol 2011; 187: 1609-1616